Achieve Life Sciences

ACHV

1.55

-0.13

-7.7%

After Hours:

1.55

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 1.56
Prev. Close: 1.68
Low/Hi: 1.43 - 1.64
52-Week: 1.26 - 10.18
Volumes
Equity: 479,050
90-Day Avg: 189,273
Option:
90-Day Avg:
Volatility
Todays Stock Vol: 157.6
20-Day (HV): 161.5
52-Week (HV): 122.0
30-Day IV: 125.4 +0.0
IV Pct Rank: 84% Elevated
Fundamental
Div. Yield:
Earnings: 2-Mar (Est.)
P/E Ratio: 0.07
Market Cap: 20.1 M
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ACHV Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2017 30-Jun-2017 31-Mar-2017 31-Dec-2016
Net Income -6,472 -2,997 -3,269 -5,843
Change in Working Capital 2,628 292 -5,880 -2,906
Depreciation Amortization Depletion and Accretion -130 37 93 40
Deferred Taxes -3,051 0 0 0
Other Non-Cash Activities 8,453 137 61 1,730
Total Cash from Operating Activities 7,323 -2,531 -8,995 -6,979
Capital Expenditures 1 0 -1 -7
Other Investing Cash Flow 2,146 760 9,470 10,421
Total Cash from Investing Activities 2,147 760 9,469 10,414
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 1,129 0 0 0
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 0 -3 -19 -2
Total Cash from Financing Activities 1,129 -3 -19 -2
Exchange Rate Effects 5 0 2 0
Net Change in Cash 10,604 -1,774 457 3,433
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Net Income -20,129 -16,801 -26,240 -31,849
Change in Working Capital -10,720 7,025 11,576 -3,931
Depreciation Amortization Depletion and Accretion 188 244 223 227
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 978 431 -2,867 -374
Total Cash from Operating Activities -29,683 -9,101 -17,308 -35,927
Capital Expenditures -46 -371 -82 -253
Other Investing Cash Flow 10,654 -1,706 5,448 32,679
Total Cash from Investing Activities 10,608 -2,077 5,366 32,426
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 0 17,643 22,402 10
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow -2 -52 2,845 0
Total Cash from Financing Activities -2 17,591 25,247 10
Exchange Rate Effects 0 0 -1 9
Net Change in Cash -19,077 6,413 13,304 -3,482